5-HT6 receptor agonist and antagonist modulates ICV-STZ-induced memory impairment in rats

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Psychopharmacology

• Publication date

  2018-03-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00213-018-4866-zPMID 29502275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 5-HT6 Receptor Agonist and Antagonist Against β-Amyloid-Peptide-Induced Neurotoxicity in PC-12 Cells

  2017cited by this paper
• Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo

  2016cited by this paper
• Serotonin, neural markers, and memory

  2015cited by this paper
• 5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia.

  2015cited by this paper
• 5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia.

  2015cited by this paper
• Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology

  2015cited by this paper
• 5-HT6 receptor agonism facilitates emotional learning

  2015cited by this paper
• Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial.

  2014cited by this paper
• Ameliorative effect of Noni fruit extract on streptozotocin-induced memory impairment in mice

  2013cited by this paper
• Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats

  2013cited by this paper
• 5-HT6 receptors and Alzheimer's disease

  2013cited by this paper
• SAR110894, a potent histamine H₃-receptor antagonist, displays procognitive effects in rodents.

  2012cited by this paper
• 5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice

  2012cited by this paper
• Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats.

  2012cited by this paper
• 5‐HT6 receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms

  2012cited by this paper
• Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.

  2011cited by this paper
• E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat

  2011cited by this paper
• Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.

  2011cited by this paper
• Neuronal and Vascular Oxidative Stress in Alzheimer’s Disease

  2011cited by this paper
• Assessment of Social Interaction Behaviors

  2011cited by this paper
• Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow.

  2010cited by this paper
• Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.

  2010cited by this paper
• Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats.

  2010cited by this paper
• 5-HT6 medicinal chemistry.

  2010cited by this paper
• Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice.

  2010cited by this paper
• Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin.

  2009cited by this paper
• Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities.

  2009cited by this paper
• Activation of 5-HT6 receptors facilitates attentional set shifting

  2009cited by this paper
• An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function.

  2008cited by this paper
• A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory.

  2008cited by this paper
• Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht6 receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task

  2008cited by this paper
• Involvement of an Altered 5-HT6 Receptor Function in Behavioral Symptoms of Alzheimer's Disease

  2008cited by this paper
• A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory

  2008cited by this paper
• The effects of the 5-HT(6) receptor agonist EMD and the 5-HT(7) receptor agonist AS19 on memory formation.

  2008cited by this paper
• Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex

  2007cited by this paper
• Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats.

  2007cited by this paper
• Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating.

  2007cited by this paper
• Acute onset by 5-HT(6)-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression.

  2007cited by this paper
• Cardiovascular disease risk factors and cognitive impairment.

  2006cited by this paper
• Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients

  2006cited by this paper
• SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.

  2006cited by this paper
• The Selective 5-HT6 Receptor Antagonist Ro4368554 Restores Memory Performance in Cholinergic and Serotonergic Models of Memory Deficiency in the Rat

  2005cited by this paper
• Laser Doppler flowmetry is valid for measurement of cerebral blood flow autoregulation lower limit in rats

  2005cited by this paper
• 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism.

  2004cited by this paper
• Effects of amphetamine on locomotor activity in adult and juvenile alcohol-preferring and -nonpreferring rats.

  2002cited by this paper
• Neurotrophins: roles in neuronal development and function.

  2001cited by this paper
• A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.

  2001cited by this paper
• 5-HT6 receptor antagonists enhance retention of a water maze task in the rat

  2001cited by this paper
• Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.

  2000cited by this paper
• Alzheimer's disease risk factors as related to cerebral blood flow.

  1996cited by this paper
• Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor

  1996cited by this paper
• Classification and nomenclature of 5-HT receptors: a comment on current issues.

  1995cited by this paper
• International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

  1994cited by this paper
• Lowry determination of protein in the presence of Triton X-100.

  1975cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• "Neuropharmacological Insights into Artesunate alone and Rivastigmine Co-Therapy: Synergistic Modulation of Cognitive Impairment in Alzheimer's Disease".

  2025cites this paper
• Repeated 5-HT6 receptor activation facilitates flexible behavior in C57BL/6J mice.

  2025cites this paper
• 5-HT6 receptors: Contemporary views on their neurobiological and pharmacological relevance in neuropsychiatric disorders

  2025cites this paper
• Modulation of the cognitive impairment associated with Alzheimer’s disease by valproic acid: possible drug repurposing

  2025cites this paper
• LOU/c/jall rat as a model of resilience in the context of streptozotocin-induced cognitive impairment

  2025cites this paper
• Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders

  2024cites this paper
• Beneficial effects of Bacopa monnieri (brahmi) in Doxorubicin-induced cardiotoxicity in rats

  2024cites this paper
• First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease

  2024cites this paper
• Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease.

  2023cites this paper
• The gut-brain axis: Effect of electroacupuncture pretreatment on learning, memory, and JNK signaling in D-galactose-induced AD-like rats

  2023cites this paper
• Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice

  2023cites this paper
• Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in sporadic Alzheimer’s rat model

  2022cites this paper
• Activation of GPR55 attenuates cognitive impairment, oxidative stress, neuroinflammation, and synaptic dysfunction in a streptozotocin-induced Alzheimer's mouse model.

  2022cites this paper
• The 5-HT6R agonist E-6837 and the antagonist SB-271046 reverse the psychotic-like behaviors induced by ketamine

  2022cites this paper
• An exit beyond the pharmacophore model for 5-HT6R agents - a new strategy to gain dual 5-HT6/5-HT2A action for triazine derivatives with procognitive potential.

  2022cites this paper
• A 5-HT6R Agonist Alleviates Cognitive Dysfunction after Traumatic Brain Injury in Rats by Increasing BDNF Expression.

  2022cites this paper
• Modulating role of serotonergic signaling in sleep and memory

  2021influential citation
• Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer’s disease

  2021cites this paper
• 7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer’s disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance

  2021cites this paper
• Serotonin 6 receptor modulation reduces locomotor activity in C57BL/6J mice.

  2021cites this paper
• The 5-HT6 receptor interactome: new insight in receptor signaling and its impact on brain physiology and pathologies.

  2020cites this paper
• Chlorine substituents and linker topology as factors of 5-HT6R activity for novel highly active 1,3,5-triazine derivatives with procognitive properties in vivo.

  2020cites this paper
• Mesenchymal Stem Cells Therapy Improved the Streptozotocin-Induced Behavioral and Hippocampal Impairment in Rats

  2019cites this paper
• Change in Expression of 5-HT6 Receptor at Different Stages of Alzheimer’s Disease: A Postmortem Study with the PET Radiopharmaceutical [18F]2FNQ1P

  2019cites this paper
• 5-HT6 receptor agonist and antagonist improve memory impairments and hippocampal BDNF signaling alterations induced by MK-801.

  2019cites this paper
• Intracerebroventricular streptozotocin induces impaired Barnes maze spatial memory and reduces astrocyte branching in the CA1 and CA3 hippocampal regions

  2018cites this paper